Drug Profile


Alternative Names: ImmStat(CO)

Latest Information Update: 29 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Oxford BioMedica
  • Class Gene therapies
  • Mechanism of Action HIV replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Suspended HIV-1 infections

Most Recent Events

  • 29 Aug 2007 Oxford BioMedica is seeking a commercialisation partner for ImmStat® (
  • 05 Sep 2001 Suspended-Preclinical for HIV-1 infections in United Kingdom (Unknown route)
  • 03 Apr 2000 ImmStat® is available for licensing (
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top